Novanta (NASDAQ:NOVT – Get Free Report) is projected to release its Q3 2026 results after the market closes on Monday, November 9th. Analysts expect the company to announce earnings of $0.9670 per share and revenue of $301.02 million for the quarter. Investors can find conference call details on the company’s upcoming Q3 2026 earnings report page for the latest details on the call scheduled for Tuesday, November 10, 2026 at 8:00 AM ET.
Novanta (NASDAQ:NOVT – Get Free Report) last posted its earnings results on Wednesday, August 5th. The technology company reported $0.89 EPS for the quarter, topping the consensus estimate of $0.83 by $0.06. Novanta had a return on equity of 10.83% and a net margin of 6.00%. The business had revenue of $265.81 million during the quarter, compared to the consensus estimate of $262.30 million. During the same quarter last year, the company earned $0.76 EPS. Novanta’s revenue was up 10.3% on a year-over-year basis. On average, analysts expect Novanta to post $3.70 EPS for the current fiscal year and $4.33 EPS for the next fiscal year.
Novanta Stock Performance
Novanta stock opened at $135.15 on Friday. The stock has a market capitalization of $5.11 billion, a price-to-earnings ratio of 42.02 and a beta of 1.71. Novanta has a 12-month low of $98.27 and a 12-month high of $176.38. The stock has a 50-day simple moving average of $142.18 and a 200 day simple moving average of $142.57. The company has a quick ratio of 3.79, a current ratio of 4.57 and a debt-to-equity ratio of 0.12.
Analysts Set New Price Targets
A number of equities research analysts have recently weighed in on the stock. Robert W. Baird set a $194.00 price target on shares of Novanta in a research report on Friday, August 7th. Wall Street Zen cut shares of Novanta from a “buy” rating to a “hold” rating in a research note on Saturday, October 24th. Zacks Research lowered Novanta from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 6th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Novanta in a report on Tuesday, October 13th. One equities research analyst has rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, Novanta has a consensus rating of “Hold” and an average target price of $194.00.
Get Our Latest Stock Analysis on NOVT
About Novanta
Novanta Inc is a technology company that develops and manufactures precision equipment and components used primarily in medical and advanced industrial applications. Its solutions are designed to support the movement, imaging, measurement and processing functions of complex equipment.
The company’s products include photonics and laser components, precision motion-control systems, medical imaging and visualization technologies, and equipment used in minimally invasive and robotic surgery.
See Also
- Five stocks we like better than Novanta
- Q3 Earnings Have Investors Wondering: Is Mercado Libre Finally a Buy?
- CVS Raised Its Outlook and Announced a Breakup—So Why Did the Stock Drop?
- Array and Shoals Are Merging: Who Really Wins the All-Stock Solar Deal?
- Duolingo’s User Growth Is Outpacing Bookings, But Is Its Strategy Paying Off?
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.
